ROME Therapeutics and Enara Bio to Host Inaugural Dark Genome Symposium Convening Industry and Academic Leaders to Catalyze Therapeutic Application of Dark Genome Research
ROME Therapeuticsand Enara Bio, two leading biotechnology companies focused on developing novel medicines driven by insights to the dark genome, today announced that they will host the inaugural Dark
United States United Kingdom Eleanor Perkin Therapeuticsand Enara Bio Frazer Hall Kostenloser Wertpapierhandel
Source: finanznachrichten.de